Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake
[In Norwegian]: Samtale Med Fastlegen Som Tiltak for å øke Covid-19-vaksinedekningen
1 other identifier
interventional
654
1 country
1
Brief Summary
The investigators will randomise individuals from family doctors' lists of patients that are at risk of severe Coronavirus Disease 2019 (COVID-19), and that are not registered as having taken the vaccine against the disease. The patients will be randomised to receiving a phone call from their family physician where the participants are given the opportunity to raise questions they might have around vaccination. The investigators will assess whether this has an impact on vaccine uptake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Dec 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 3, 2021
CompletedFirst Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
January 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedMay 29, 2025
January 1, 2022
5 months
December 8, 2021
May 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vaccination status (COVID-19)
Change in proportion of participants who are registered in the national vaccination registry, as having received at least one dose of a COVID-19 vaccine.
3-6 weeks after inclusion
Study Arms (2)
Telephone call from family physician
EXPERIMENTALIndividuals allocated to the experimental arm will receive a phone call from the their family physician, where they are offered the opportunity to raise questions they might have about the COVID-19 vaccine.
Usual care
NO INTERVENTIONInterventions
Participants receive phone call from their family physician, where they are invited to ask questions about the COVID-19 vaccine.
Eligibility Criteria
You may qualify if:
- Belonging to group at risk of severe COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bolteløkka legesenter
Oslo, 0168, Norway
Related Publications (1)
Tuv M, Elgersma IH, Furuseth E, Holst C, Helleve A, Fretheim A. GP phone calls to improve COVID-19 vaccine uptake among patients at increased risk of severe COVID-19: a randomised trial. BJGP Open. 2023 Jun 27;7(2):BJGPO.2022.0175. doi: 10.3399/BJGPO.2022.0175. Print 2023 Jun.
PMID: 36754551BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Atle Fretheim, PhD
Norwegian Institute of Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2021
First Posted
January 26, 2022
Study Start
December 3, 2021
Primary Completion
April 28, 2022
Study Completion
June 30, 2022
Last Updated
May 29, 2025
Record last verified: 2022-01